Since 2007, the company has been operating well, with rapid growth in operating income and net profit. The compound growth rate of operating income in three years exceeds 70%, profits have doubled year after year, and online transactions have grown rapidly. Various financial indicators have increased substantially.
The company has also innovated its business model, changed the simple wholesale mode of earning drugs, and provided brand promotion, online marketing, data sharing, software and information services for upstream and downstream users. Revenue from value-added services has increased substantially year by year.